CC Pharma Nordic ApS: Financial statements 2020
CVR: 39461528
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CC Pharma Nordic ApS (CVR 39461528) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 121,382 and a net result of DKK -589,254 compared with DKK -830,910 the year before. Equity in the 2020 report amounted to DKK -1,689,540. The company had 1 employee in the financial year.
- Gross Profit
- DKK 121,382
- Profit/Loss
- DKK -589,254
- Equity
- DKK -1,689,540
- Total Assets
- DKK 4,636,582
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 121 t. | -589 t. | -1.7 mio. | 1 |
| 2019 | - | -194 t. | -831 t. | -1.1 mio. | 1 |
Official annual report
How creditworthy is CC Pharma Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 18, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of CC Pharma Nordic ApS.
As of December 18, 2020, EY Danmark A/S has stepped down as auditor of CC Pharma Nordic ApS.
CC Pharma Nordic ApS has published its annual report for 2019. Gross profit came to DKK -194,048, and the net result was DKK -830,910.
About CC Pharma Nordic ApS
CC Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 7 January 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Astea Pharma ApS. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025.